Paysign, Inc.

Fundamentals5.0
Price Action4.0
News Sentiment7.0
AI Rating
5.0

Key Drivers

  • Margin Expansion
  • Weak Cash Flow
  • Liquidity Pressure

AI
AI Summary

5.0

PAYS is evolving into a higher-margin life-sciences payments platform, but after its sharp rerating, investors should only add exposure if patient-affordability growth and elevated margins translate into sustained free cash flow rather than working-capital-driven earnings.

LifeSciencesGrowth
CashConversionRisk
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • •Margin Expansion
  • •Weak Cash Flow
  • •Liquidity Pressure

PAYS shows improving profitability and low debt, but weak cash conversion, tight working capital, and elevated valuation warrant caution.

Profitability
Overvalued

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Recent rebound
  • •Below average
  • •Resistance overhead

PAYS remains cautiously bearish last month, rebounding from $11.82 but needing to reclaim $12.80–$13.00 while holding $11.82–$12.00 support.

Bearish
Watchlist
Support Level: $11.82–$12.00
Resistance Level: $12.80–$13.00

Rebounded from $11.82 on 2026-09-16 to $12.34 by 2026-09-18

Sentiment & News

7.0

Key News Insights:

  • •Zacks upgrade
  • •Revenue target
  • •BlackRock stake

Paysign's upgraded outlook, $117M revenue target, and BlackRock stake signal strengthening growth momentum.

Paysign
Growth

The news is broadly positive for Paysign, potentially supporting investor confidence and share demand